scholarly journals Pregnancy incidence and associated factors among HIV-infected female adolescents in HIV care in urban Côte d'Ivoire, 2009–2013

2016 ◽  
Vol 9 (1) ◽  
pp. 31622 ◽  
Author(s):  
Shino Arikawa ◽  
Tanoh Eboua ◽  
Kouadio Kouakou ◽  
Marie-Sylvie N'Gbeche ◽  
Madeleine Amorissani-Folquet ◽  
...  
BMC Nutrition ◽  
2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Julie Jesson ◽  
Ayoko Ephoevi-Ga ◽  
Marie-Hélène Aké-Assi ◽  
Sikiratou Koumakpai ◽  
Sylvie N’Gbeche ◽  
...  

Abstract Background Nutritional care is not optimally integrated into pediatric HIV care in sub-Saharan Africa. We assessed the 6-month effect of a nutritional support provided to children living with HIV, followed in a multicentric cohort in West Africa. Methods In 2014-2016, a nutritional intervention was carried out for children living with HIV, aged under 10 years, receiving antiretroviral therapy (ART) or not, in five HIV pediatric cohorts, in Benin, Togo and Côte d’Ivoire. Weight deficiency was assessed using two definitions: wasting (Weight for Height Z-score [WHZ] for children<5 years old or Body-Mass-Index for Age [BAZ] for ≥5 years) and underweight (Weight for Age Z-score [WAZ]) (WHO child growth standards). Combining these indicators, three categories of nutritional support were defined: 1/ children with severe malnutrition (WAZ and/or WHZ/BAZ <-3 Standard Deviations [SD]) were supported with Ready-To-Use Therapeutic Food (RUTF), 2/ those with moderate malnutrition (WAZ and/or WHZ/BAZ = [-3;-2[ SD) were supported with fortified blended flours produced locally in each country, 3/ those non malnourished (WAZ and WHZ/BAZ ≥-2 SD) received nutritional counselling only. Children were followed monthly over 6 months. Dietary Diversity Score (DDS) using a 24h recall was measured at the first and last visit of the intervention. Results Overall, 326 children were included, 48% were girls. At baseline, 66% were aged 5-10 years, 91% were on ART, and 17% were severely immunodeficient (CD4 <250 cells/mL or CD4%<15). Twenty-nine (9%) were severely malnourished, 63 (19%) moderately malnourished and 234 (72%) non-malnourished. After 6 months, 9/29 (31%) and 31/63 (48%) recovered from severe and moderate malnutrition respectively. The median DDS was 8 (IQR 7-9) in Côte d’Ivoire and Togo, 6 (IQR 6-7) in Benin. Mean DDS was 4.3/9 (sd 1.2) at first visit, with a lower score in Benin, but with no difference between first and last visit (p=0.907), nor by intervention groups (p-value=0.767). Conclusions This intervention had a limited effect on nutritional recovery and dietary diversity improvement. Questions remain on determining appropriate nutritional products, in terms of adherence, proper use for families and adequate energy needs coverage for children living with HIV. Trial registration PACTR202001816232398, June 01, 2020, retrospectively registered.


Author(s):  
Ekra Kouadio Daniel ◽  
Okoubo Guillaume ◽  
Orsot Tetchi ◽  
Ekou Kokora Franck

Objectives: To estimate the current national prevalence of hypertension and to identify associated factors, in a context of increasing cardiovascular diseases and rampant urbanization in Côte d'Ivoire. Methodology: This was a secondary analysis of data from the survey on the prevalence and characteristics of diabetes in Côte d'Ivoire. The cross-sectional, descriptive and analytical study was conducted among 3198 adults aged 20 to 79 years, in the twenty health regions of Côte d'Ivoire from 23 November to 22 December 2017. Risk factors were identified by binary stepwise logistic regression using Stata version 15 software. Results: The survey population was predominantly female (55%) and lived in urban areas (55.38%). The prevalence of hypertension in Côte d'Ivoire was 39.92% [95% CI : 37.28 - 42.62]. Independent of other factors, hypertension in adults is associated with age, place of residence, education level, marital status, income and nutritional status. However, the consumption of fruits and vegetables is protective of hypertension. Conclusion: The prevalence of hypertension in Côte d'Ivoire is very high with a greater burden in the older populations. Interventions targeting the associated modifiable risk factors are needed to correct this alarming epidemiological situation.


PLoS ONE ◽  
2019 ◽  
Vol 14 (3) ◽  
pp. e0211385 ◽  
Author(s):  
Natalie Jean Tibbels ◽  
Zoé Mistrale Hendrickson ◽  
Danielle Amani Naugle ◽  
Abdul Dosso ◽  
Lynn Van Lith ◽  
...  

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Nicolas Rouveau ◽  
◽  
Odette Ky-Zerbo ◽  
Sokhna Boye ◽  
Arlette Simo Fotso ◽  
...  

Abstract Background The ATLAS programme aims to promote and implement HIV self-testing (HIVST) in three West African countries: Côte d’Ivoire, Mali, and Senegal. During 2019–2021, in close collaboration with the national AIDS implementing partners and communities, ATLAS plans to distribute 500,000 HIVST kits through eight delivery channels, combining facility-based, community-based strategies, primary and secondary distribution of HIVST. Considering the characteristics of West African HIV epidemics, the targets of the ATLAS programme are hard-to-reach populations: key populations (female sex workers, men who have sex with men, and drug users), their clients or sexual partners, partners of people living with HIV and patients diagnosed with sexually transmitted infections and their partners. The ATLAS programme includes research support implementation to generate evidence for HIVST scale-up in West Africa. The main objective is to describe, analyse and understand the social, health, epidemiological effects and cost-effectiveness of HIVST introduction in Côte d’Ivoire, Mali and Senegal to improve the overall HIV testing strategy (accessibility, efficacy, ethics). Methods ATLAS research is organised into five multidisciplinary workpackages (WPs): Key Populations WP: qualitative surveys (individual in-depth interviews, focus group discussions) conducted with key actors, key populations, and HIVST users. Index testing WP: ethnographic observation of three HIV care services introducing HIVST for partner testing. Coupons survey WP: an anonymous telephone survey of HIVST users. Cost study WP: incremental economic cost analysis of each delivery model using a top-down costing with programmatic data, complemented by a bottom-up costing of a representative sample of HIVST distribution sites, and a time-motion study for health professionals providing HIVST. Modelling WP: Adaptation, parameterisation and calibration of a dynamic compartmental model that considers the varied populations targeted by the ATLAS programme and the different testing modalities and strategies. Discussion ATLAS is the first comprehensive study on HIV self-testing in West Africa. The ATLAS programme focuses particularly on the secondary distribution of HIVST. This protocol was approved by three national ethic committees and the WHO’s Ethical Research Committee.


PLoS ONE ◽  
2021 ◽  
Vol 16 (12) ◽  
pp. e0260530
Author(s):  
Tamsin K. Phillips ◽  
Halli Olsen ◽  
Chloe A. Teasdale ◽  
Amanda Geller ◽  
Mamorapeli Ts’oeu ◽  
...  

Transitions between services for continued antiretroviral treatment (ART) during and after pregnancy are a commonly overlooked aspect of the HIV care cascade, but ineffective transitions can lead to poor health outcomes for women and their children. In this qualitative study, we conducted interviews with 15 key stakeholders from Ministries of Health along with PEPFAR-supported and other in-country non-governmental organizations actively engaged in national programming for adult HIV care and prevention of mother-to-child-transmission of HIV (PMTCT) services in Côte d’Ivoire, Lesotho and Malawi. We aimed to understand perspectives regarding transitions into and out of PMTCT services for continued ART. Thematic analysis revealed that, although transitions of care are necessary and a potential point of loss from ART care in all three countries, there is a lack of clear guidance on transition approach and no formal way of monitoring transition between services. Several opportunities were identified to monitor and strengthen transitions of care for continued ART along the PMTCT cascade.


2019 ◽  
Vol 29 (2) ◽  
pp. 127-131 ◽  
Author(s):  
V. Djohan ◽  
K.E. Angora ◽  
A.H. Vanga-Bosson ◽  
A. Konaté ◽  
K.F. Kassi ◽  
...  

PLoS ONE ◽  
2021 ◽  
Vol 16 (7) ◽  
pp. e0255074
Author(s):  
Rachel D. Stelmach ◽  
Miriam Rabkin ◽  
Kouame Abo ◽  
Irma Ahoba ◽  
Mahena Gildas Anago ◽  
...  

Background Although people living with HIV in Côte d’Ivoire receive antiretroviral therapy (ART) at no cost, other out-of-pocket (OOP) spending related to health can still create a barrier to care. Methods A convenience sample of 400 adults living with HIV for at least 1 year in Côte d’Ivoire completed a survey on their health spending for HIV and chronic non-communicable diseases (NCDs). In addition to descriptive statistics, we performed simple linear regression analyses with bootstrapped 95% confidence intervals. Findings 365 participants (91%) reported OOP spending for HIV care, with a median of $16/year (IQR 5–48). 34% of participants reported direct costs with a median of $2/year (IQR 1–41). No participants reported user fees for HIV services. 87% of participants reported indirect costs, with a median of $17/year (IQR 7–41). 102 participants (26%) reported at least 1 NCD. Of these, 80 (78%) reported OOP spending for NCD care, with a median of $50/year (IQR 6–107). 76 participants (95%) with both HIV and NCDs reported direct costs, and 48% reported paying user fees for NCD services. Participants had missed a median of 2 HIV appointments in the past year (IQR 2–3). Higher OOP costs were not associated with the number of HIV appointments missed. 21% of participants reported spending over 10% of household income on HIV and/or NCD care. Discussion and conclusions Despite the availability of free ART, most participants reported OOP spending. OOP costs were much higher for participants with co-morbid NCDs.


Sign in / Sign up

Export Citation Format

Share Document